Taiwan grants EUA for 2nd-generation Moderna COVID-19 vaccine (update)

Taiwan's Food and Drug Administration(FDA) has granted emergency use authorization (EUA) for Moderna's second-generation COVID-19 vaccines for adults aged 18 years old and above, after a meeting of experts Friday.

(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)